From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC
Pathology - Research and Practice · 2025-11 · 275 · 156249
DOI: 10.1016/j.prp.2025.156249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025-11. Verfasst von Anshu Kapadia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hemato Oncology Center Rajpath, India. Electronic address: anshu.cmhp@gmail.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inflammatory Bowel Diseases, Inflammation, Carcinogenesis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Inflammatory bowel disease-associated colorectal cancer (IBD-CRC) represents a distinct clinical and molecular entity compared with sporadic colorectal cancer (CRC). While sporadic CRC arises through the adenoma-carcinoma sequence, IBD-CRC follows an inflammation-dysplasia-carcinoma pathway, characterized by early TP53 alterations, multifocality, and flat lesions that challenge detection. Contemporary epidemiology indicates declining IBD-CRC incidence in high-income regions due to improved surveillance, though risk remains elevated in subgroups with long-standing colitis, primary sclerosing cholangitis (PSC), or persistent inflammation. In contrast, underreporting in low- and middle-income countries obscures the true global burden. Advances in high-definition colonoscopy and chromoendoscopy have improved detection, yet optimal risk-adapted surveillance strategies remain underutilized. Molecular insights highlight differences in genetic alterations, immune evasion, and microbial drivers between IBD-CRC and sporadic CRC. This review synthesizes epidemiologic, pathogenetic, and clinical distinctions, underscores challenges in surveillance and reporting, and discusses emerging technologies-including liquid biopsy, artificial intelligence, and multi-omics-that may refine prevention and early detection. Recognition of IBD-CRC as a separate disease process is essential to optimize individualized risk stratification, surveillance algorithms, and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hemato Oncology Center Rajpath, India. Electronic address: anshu.cmhp@gmail.com.
- Hemato Oncology Center Rajpath, India. Electronic address: drashtijoshi2898@gmail.com.
- Hemato Oncology Center Rajpath, India. Electronic address: ankitchavda6379@gmail.com.
- Hemato Oncology Center Rajpath, India. Electronic address: parloop72@gmail.com.
Zitieren
APA
Kapadia, A., Joshi, D., Chavda, A., & Bhatt, P. (2025). From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC. Pathology - Research and Practice, 275, 156249. https://doi.org/10.1016/j.prp.2025.156249
Vancouver
Kapadia A, Joshi D, Chavda A, Bhatt P. From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC. Pathology - Research and Practice. 2025;275:156249. doi:10.1016/j.prp.2025.156249
BibTeX
@article{Kapadia2025,
author = {Kapadia, Anshu and Joshi, Drasti and Chavda, Ankit and Bhatt, Parloop},
title = {From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC},
journal = {Pathology - Research and Practice},
year = {2025},
volume = {275},
pages = {156249},
doi = {10.1016/j.prp.2025.156249}
}
EUVIMED